Detecting drug-induced changes in ECG parameters using jacketed telemetry: Effect of different data reduction...

Area of Science:

• Preclinical pharmacology
• Cardiovascular safety assessment
• Drug discovery and development

Background:

• Continuous cardiovascular data, such as electrocardiogram (ECG) recordings, are crucial in preclinical safety assessments.
• Analyzing large volumes of continuous ECG data requires effective summarization techniques to interpret drug effects.
• Assessing various data reduction methods is essential to optimize the statistical power of safety assays.

Purpose of the Study:

• To evaluate four distinct data reduction methods for continuous ECG data.
• To determine the impact of these methods on the statistical power of preclinical cardiovascular safety assays.
• To compare the efficacy of different averaging durations in detecting drug-induced ECG changes.

Main Methods:

• Continuous ECG data were collected from cynomolgus monkeys using telemetry.
• Animals received either vehicle or moxifloxacin at ascending doses.
• ECG recordings were reduced using 1-min, 15-min, large duration (0.5-4h), and super-interval (3.5-9h) averages.

Main Results:

• 1-min, 15-min, and large duration averages demonstrated comparable ability to detect moxifloxacin-induced QTc prolongation.
• Super-intervals detected slightly smaller QTc changes but failed to detect significant increases at the lowest moxifloxacin dose.
• Fewer spurious significant differences were observed between dosing days with large duration averages and super-intervals.

Conclusions:

• No significant difference in detecting drug-induced ECG changes was found between small and large duration average data reduction techniques.
• Larger duration averages or super-intervals may improve data interpretation by minimizing chance-based significant differences.
• These findings support the use of appropriate data reduction strategies for robust preclinical cardiovascular safety evaluations.